Dr Nikolai Tankovich
Dr. Nikolai Tankovich is a recognized innovator, researcher and educator for laser applications in medicine, cancer vaccines, stem cell therapies and other medical related disciplines. He is a proven researcher and has inventions that have set the basis for entire new industries. Founder and Director of several corporations, Dr. Tankovich is respected worldwide and published and honored for his innovative work in laser and new drug usage including medical and aesthetic applications. He has more than 110 U.S. and other foreign patents issued and pending.
Dr. Tankovich holds an MD degree from Semashco Medical University (Moscow), a Master of Science degree in Plasma Physics from Moscow University, and a PhD in BioPhysics from Lomonosov Moscow University. He has been an educator at international universities, published more than 60 articles and has been a presenter or speaker at over 200 conferences or seminars. He has conducted extensive research and development of laser applications for medical usage as well as for cancer research. Among his numerous awards and honors is the Gold Kurchatov Medal for the Atomic Science Application in Medicine and Biology awarded by the Atomic Energy Agency in 1998. Dr. Tankovich's inventions include devices for laser hair removal and laser skin peeling, non-ablative wrinkle removal and laser lancet (all three licensed and FDA approved). He was the first in the world to propose, invent, develop, patent, build and use a 1.54 micron Er:Glass laser for medical applications. He is a former scientific advisor to Reliant Technologies (now Solta Medical) and is the pioneer of the science of Laser Sparing Technology, the supporting intellectual property of the Fraxel Laser and the genesis of what is now known as fractional photothermolysis.
Dr. Tankovich has conducted extensive research and development of laser applications for medical usage. As a result of his advanced technology laser applications in plastic and cosmetic surgery and dermatology, ThermoLase Corporation was founded and still uses his intellectual property and patents on laser hair removal and skin resurfacing. In the early 90s, Nikolai Tankovich, MD, PhD pioneered the development of fractional non-ablative lasers with the invention of a 1500 nm device for dermatological treatments. The initial device, a manual operation with a 1mm diameter spot size, marked the beginning. Over time, technological advancements led to a scanner-equipped laser, reducing operator fatigue and enhancing treatment efficiency. This upgraded version, incorporating skin cooling technology, was patented in 2003 and launched in 2007. Dr. Tankovich's dedication persisted, culminating in the 2020 patent for MultiFrax, a cutting-edge fractional non-ablative device utilizing diode lasers and contemporary technology for increased effectiveness.
